Proof of concept trial of bromfenac ophthalmic solution for inhibitory effect against inflammatory cytokines.
Not Applicable
- Conditions
- Patients with pseudophakic eye
- Registration Number
- JPRN-UMIN000017934
- Lead Sponsor
- Department of Ophthalmology, Faculty of Medical Science, University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with a history of hypersensitivity against bromfenac and fluorometholone 2)Patients with ocular infections and inflammation (including allergic conjunctivitis and vernal keratoconjunctivitis) 3)Patients who received the ophthalmic surgery (including laser) within three months. 4)Patients with systemic diseases that may affect the efficacy or safety of the test drugs 5)Patients who was judged to be inappropriate as a subject by doctor in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the cytokine concentration difference (before and 8 days after drug administration) between test drug groups
- Secondary Outcome Measures
Name Time Method Comparison of the cytokine concentration between before and 8 days after drug administration in the same group